Skip to content

Boston Scientific BSX Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

Abbott logo
AbbottABT
Edwards Lifesciences logo
Edwards LifesciencesEW
STERIS logo
STERISSTE
Intuitive Surgical logo
Intuitive SurgicalISRG
ResMed logo
ResMedRMD
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's preferred stock, par or stated value per share?
Boston Scientific (BSX) reported preferred stock, par or stated value per share of $0.01 in Q1 2026.
How has Boston Scientific's preferred stock, par or stated value per share changed year-over-year?
Boston Scientific's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for Boston Scientific's preferred stock, par or stated value per share?
Over 5 years (2020 to 2025), Boston Scientific's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.